Literature DB >> 23735187

Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.

Jennifer G Goldman1, Reena A Ghode, Bichun Ouyang, Bryan Bernard, Christopher G Goetz, Glenn T Stebbins.   

Abstract

BACKGROUND: Daytime and nighttime sleep disturbances and cognitive impairment occur frequently in Parkinson's disease (PD), but little is known about the interdependence of these non-motor complications. Thus, we examined the relationships among excessive daytime sleepiness, nighttime sleep quality and cognitive impairment in PD, including severity and specific cognitive deficits.
METHODS: Ninety-three PD patients underwent clinical and neuropsychological evaluations including the Epworth Sleepiness Scale (ESS) and Pittsburgh Sleep Quality Index (PSQI). Patients were classified as having normal cognition (PD-NC), mild cognitive impairment (PD-MCI), or dementia (PDD) using recently proposed Movement Disorder Society PD-MCI and PDD criteria. Relationships between the sleep and cognitive measures and PD cognitive groups were examined.
RESULTS: The PD cohort included PD-NC (n = 28), PD-MCI (n = 40), and PDD (n = 25) patients. ESS scores, as a measure of daytime sleepiness, were significantly worse (p = 0.005) in cognitively impaired PD patients, particularly PDD patients. ESS scores correlated significantly with Mini-Mental State Examination scores and also with cognitive domain scores for attention/working memory, executive function, memory, and visuospatial function. In contrast, PSQI scores, as a measure of nighttime sleep quality, neither differed among cognitive groups nor correlated with any cognitive measures.
CONCLUSIONS: Daytime sleepiness in PD, but not nighttime sleep problems, is associated with cognitive impairment in PD, especially in the setting of dementia, and attention/working memory, executive function, memory, and visuospatial deficits. The presence of nighttime sleep problems is pervasive across the PD cognitive spectrum, from normal cognition to dementia, and is not independently associated with cognitive impairment or deficits in cognitive domains.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dementia; Excessive daytime sleepiness; Executive function; MCI (mild cognitive impairment); Parkinson's disease; Sleep disorders

Mesh:

Year:  2013        PMID: 23735187      PMCID: PMC3729741          DOI: 10.1016/j.parkreldis.2013.05.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  31 in total

1.  A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study.

Authors:  Ronald B Postuma; Isabelle Arnulf; Birgit Hogl; Alex Iranzo; Tomoyuki Miyamoto; Yves Dauvilliers; Wolfgang Oertel; Yo-El Ju; Monica Puligheddu; Poul Jennum; Amelie Pelletier; Christina Wolfson; Smaranda Leu-Semenescu; Birgit Frauscher; Masayuki Miyamoto; Valerie Cochen De Cock; Marcus M Unger; Karin Stiasny-Kolster; Maria Livia Fantini; Jacques Y Montplaisir
Journal:  Mov Disord       Date:  2012-05-30       Impact factor: 10.338

2.  FAST TRACK: daytime sleepiness in Parkinson's disease.

Authors:  D B Rye; D L Bliwise; B Dihenia; P Gurecki
Journal:  J Sleep Res       Date:  2000-03       Impact factor: 3.981

3.  Development of daytime somnolence over time in Parkinson's disease.

Authors:  M D Gjerstad; D Aarsland; J P Larsen
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

4.  Daytime sleepiness and other sleep disorders in Parkinson's disease.

Authors:  W G Ondo; K Dat Vuong; H Khan; F Atassi; C Kwak; J Jankovic
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

5.  Parkinson's disease and sleepiness: an integral part of PD.

Authors:  I Arnulf; E Konofal; M Merino-Andreu; J L Houeto; V Mesnage; M L Welter; L Lacomblez; J L Golmard; J P Derenne; Y Agid
Journal:  Neurology       Date:  2002-04-09       Impact factor: 9.910

6.  Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study.

Authors:  Ronald B Postuma; Josie-Anne Bertrand; Jacques Montplaisir; Catherine Desjardins; Mélanie Vendette; Silvia Rios Romenets; Michel Panisset; Jean-François Gagnon
Journal:  Mov Disord       Date:  2012-02-09       Impact factor: 10.338

Review 7.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

8.  Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.

Authors:  Sebastian Paus; Hans Michael Brecht; Jürgen Köster; Gert Seeger; Thomas Klockgether; Ullrich Wüllner
Journal:  Mov Disord       Date:  2003-06       Impact factor: 10.338

9.  Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease.

Authors:  Padraig E O'Suilleabhain; Richard B Dewey
Journal:  Arch Neurol       Date:  2002-06

10.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

View more
  29 in total

1.  Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden; Bryan Bernard; Bichun Ouyang; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

2.  Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Authors:  Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton
Journal:  J Clin Exp Neuropsychol       Date:  2019-06-10       Impact factor: 2.475

3.  The correlation of non-motor symptoms and sleep on balance in Parkinson's disease patients with normal cognition and mild cognitive impairment.

Authors:  Mevhibe Saricaoglu; Nesrin Helvaci Yilmaz; Fahriye Feriha Ozer; Lutfu Hanoglu
Journal:  Ir J Med Sci       Date:  2021-01-15       Impact factor: 1.568

4.  Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS.

Authors:  Jennifer G Goldman; Glenn T Stebbins; Vania Leung; Barbara C Tilley; Christopher G Goetz
Journal:  Parkinsonism Relat Disord       Date:  2014-08-13       Impact factor: 4.891

Review 5.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

6.  Daytime sleepiness and nighttime sleep quality across the full spectrum of cognitive presentations in essential tremor.

Authors:  Brittany Rohl; Kathleen Collins; Sarah Morgan; Stephanie Cosentino; Edward D Huey; Elan D Louis
Journal:  J Neurol Sci       Date:  2016-10-08       Impact factor: 3.181

7.  High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra.

Authors:  Zheng Zhong; Douglas Merkitch; M Muge Karaman; Jiaxuan Zhang; Yi Sui; Jennifer G Goldman; Xiaohong Joe Zhou
Journal:  Radiology       Date:  2019-02-19       Impact factor: 11.105

8.  Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate?

Authors:  David R Shprecher; Charles H Adler; Nan Zhang; Holly A Shill; Christine M Belden; Erika Driver-Dunckley; Shyamal H Mehta; Kathryn J Davis; Lucia I Sue; Edward Zamrini; Thomas G Beach
Journal:  Clin Neurol Neurosurg       Date:  2020-02-06       Impact factor: 1.876

9.  Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.

Authors:  Jennifer G Goldman; Glenn T Stebbins; Vy Dinh; Bryan Bernard; Doug Merkitch; Leyla deToledo-Morrell; Christopher G Goetz
Journal:  Brain       Date:  2014-01-29       Impact factor: 13.501

10.  Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?

Authors:  Jennifer G Goldman; Samantha Holden; Bichun Ouyang; Bryan Bernard; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2014-12-01       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.